TeleZen MD Review

Our assessment

The figure in TeleZen MD's headline is the twelve-month prepayment, and two of the three places it appears don't say so. Look past the hero and the page is good. Four plan lengths for each of two compounded molecules, the per-month figure and the prepaid total on the same card, and four physicians named right beside the prices.

Four terms per drug, with the total beside each rate

Each drug gets a monthly plan, a quarterly plan, a semi-annual plan and an annual plan. Every one prints a per-month figure and, right beside it, the amount actually charged and how often.

That pairing is the whole point. A per-month figure worked out from a year's prepayment is not the same number as a month-to-month rate, and a card showing both makes the difference visible instead of leaving you to do the arithmetic.

The FAQ on the same page adds that all doses cost the same. Titrating up doesn't raise the bill on either molecule, and TeleZen MD says so outright rather than implying it with a starting figure.

Every plan itemizes what it includes: the physician consultation, the provider monitoring, the compounded medication and expedited shipping.

The advertised figure is the year

The priced page leads with a per-month figure three times: in the hero, in a repeat hero and in the closing call to action. That figure is the twelve-month prepayment. Two of those three times, no term appears beside it.

The month-to-month rate is materially higher and appears only inside the plan card, further down the page. Take the hero at face value and you carry the wrong number into every comparison you make.

Nothing is hidden here. The plan card publishes everything. But the first thing you see advertises the deepest commitment as though it were the standing rate.

Named physicians on the priced page itself

Four physicians are named on the same page that carries the prices, each with a credential and either a board certification or a training institution. One carries two named board certifications.

Naming clinicians at all is uncommon; naming them on the priced page rather than in a buried bio is rarer still. You can check these names against a public register before you decide anything.

The pharmacies are not named. They are described as United States, state-regulated 503A and 503B compounding facilities, which is a class rather than an answer.

No brand-name product is sold. None of the brand names appears on the homepage, the priced GLP-1 page, the FAQ or the about page, so compounded is the only route priced here.

Coverage answered, social proof not

Asked directly whether it serves all fifty states, the FAQ says yes, subject to medical eligibility and state regulations. The homepage carries the same question and the same answer. That is a claim in words rather than a badge, which at least gives you something to quote back.

The membership question is answered three separate times: no membership fees, no contracts and no cancellation conditions, on the FAQ, the GLP-1 page and the homepage.

The member-count and review-percentage claims are a different matter. They are printed with no date, no source and no sample size, so there is nothing behind them to check.